Design and synthesis of novel disease-modifying anti-Alzheimer compounds
Healthy ageing is becoming increasingly threatened by a number of age-related neurodegenerative diseases, including Alzheimer’s disease (AD). AD causes loss…
Warning: Uninitialized string offset 0 in /www/wub/medicinalchemistrypharmacology/wp-content/themes/generatepress_child/functions.php on line 140
Warning: Uninitialized string offset 0 in /www/wub/medicinalchemistrypharmacology/wp-content/themes/generatepress_child/functions.php on line 140
Warning: Uninitialized string offset 0 in /www/wub/medicinalchemistrypharmacology/wp-content/themes/generatepress_child/functions.php on line 140
Read More »
New imidazoline I2-receptor ligands to face neurodegenerative diseases
Humanity is facing a vast prevalence of neurodegenerative diseases, with Alzheimer’s disease (AD) being the most dominant, without efficacious drugs,…
G9a Inhibition Promotes Neuroprotection through GMFB Regulation in Alzheimer’s Disease by Bellver-Sanchis et al.
New work published in Aging and Disease by Bellver-Sanchis et al. Abstract: Epigenetic alterations are a fundamental pathological hallmark of…